These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 3416661)
1. Multiple transport pathways for L1210 cells: uptake of PTT.119, a bifunctional alkylator with carrier amino acids. Yagi MJ; Scanlon KJ; Chin SE; Holland JF; Bekesi JG Chemotherapy; 1988; 34(3):235-47. PubMed ID: 3416661 [TBL] [Abstract][Full Text] [Related]
2. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines. Yagi MJ; Chin SE; Scanlon KJ; Holland JF; Bekesi JG Biochem Pharmacol; 1985 Jul; 34(13):2347-54. PubMed ID: 4040366 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell. Vistica DT Biochim Biophys Acta; 1979 Jan; 550(2):309-17. PubMed ID: 569503 [TBL] [Abstract][Full Text] [Related]
4. Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicity. Yagi MJ; Bekesi JG; Daniel MD; Holland JF; De Barbieri A Cancer Chemother Pharmacol; 1984; 12(2):70-6. PubMed ID: 6421500 [TBL] [Abstract][Full Text] [Related]
5. Mammary tumor and melanoma cell transport of PTT.119, a bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. Yagi MJ; Scanlon KJ; Chin SE; Bekesi JG Chemotherapy; 1988; 34(1):61-70. PubMed ID: 2832130 [TBL] [Abstract][Full Text] [Related]
6. Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl. Yagi MJ; Bekesi JG Biomed Pharmacother; 1983; 37(7):329-38. PubMed ID: 6667339 [TBL] [Abstract][Full Text] [Related]
7. Interference of mouse mammary tumor virus replication by PTT.119 [p-fluoro-L-phe-m-bis-(2-chloroethyl)amino-L-phe-met ethoxy HCl]--an antitumor agent. Yagi MJ; Maldarelli F; Chin SE; Holland JF; Bekesi JG J Natl Cancer Inst; 1986 Mar; 76(3):493-501. PubMed ID: 3005743 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity as an indicator for transport mechanism: evidence that murine bone marrow progenitor cells lack a high-affinity leucine carrier that transports melphalan in murine L1210 leukemia cells. Vistica DT Blood; 1980 Sep; 56(3):427-9. PubMed ID: 7407411 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of alpha-aminoisobutyric acid transport by lactating rat mammary gland. Shennan DB; McNeillie SA J Dairy Res; 1994 Feb; 61(1):9-19. PubMed ID: 8188948 [TBL] [Abstract][Full Text] [Related]
10. Effects of amino acids on the transport and cytotoxicity of melphalan by human bone marrow cells and human tumor cells. Dufour M; Panasci LC; St Germain J; Boulet L Cancer Chemother Pharmacol; 1985; 15(2):125-31. PubMed ID: 4017161 [TBL] [Abstract][Full Text] [Related]
11. Characterization of neutral and cationic amino acid transport in Xenopus oocytes. Campa MJ; Kilberg MS J Cell Physiol; 1989 Dec; 141(3):645-52. PubMed ID: 2592432 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia. Yagi MJ; Bekesi JG Cancer Chemother Pharmacol; 1990; 26(3):215-20. PubMed ID: 2357770 [TBL] [Abstract][Full Text] [Related]
13. Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay. Yagi MJ; Zanjani M; Holland JF; Bekesi JG Cancer Chemother Pharmacol; 1984; 12(2):77-82. PubMed ID: 6697428 [TBL] [Abstract][Full Text] [Related]
14. System ASC and sodium-independent neutral amino acid transport in muscle of uremic rats. Maroni BJ; Karapanos G; Mitch WE Am J Physiol; 1986 Jul; 251(1 Pt 2):F81-6. PubMed ID: 3524267 [TBL] [Abstract][Full Text] [Related]
15. Evidence for increased intracellular transport of m-sarcolysine (alkylating moiety) when combined with two amino acid analogs (PTT-119). Verlicchi F; Boschi S; Visani G; Guidi A; Tosi P; Cavo M; Tura S Blut; 1990 Nov; 61(5):311-3. PubMed ID: 2271778 [TBL] [Abstract][Full Text] [Related]
16. Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine. Langen KJ; Mühlensiepen H; Holschbach M; Hautzel H; Jansen P; Coenen HH J Nucl Med; 2000 Jul; 41(7):1250-5. PubMed ID: 10914918 [TBL] [Abstract][Full Text] [Related]
17. Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cells. Vistica DT; Toal JN; Rabinovitz M Cancer Treat Rep; 1976 Sep; 60(9):1363-7. PubMed ID: 1016969 [TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines. Ono M; Oka S; Okudaira H; Schuster DM; Goodman MM; Kawai K; Shirakami Y Brain Res; 2013 Oct; 1535():24-37. PubMed ID: 23994214 [TBL] [Abstract][Full Text] [Related]
19. Neutral amino acid transport in embryonal carcinoma cells. Zuzack JS; Tasca RJ; DiZio SM J Cell Physiol; 1985 Mar; 122(3):379-86. PubMed ID: 3968192 [TBL] [Abstract][Full Text] [Related]
20. A multicomponent analysis of amino acid transport systems in human lymphocytes. 1. Kinetic parameters of the A and L systems and pathways of uptake of naturally occurring amino acids in blood lymphocytes. Segel GB; Simon W; Lichtman MA J Cell Physiol; 1983 Sep; 116(3):372-8. PubMed ID: 6604062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]